Under “diabetes-like” stress, the phosphomimetic (148D) HspB4/αA-crystallin mutant was even more effective at reducing the pro-inflammatory mediator’s response of MGCs (HspB4−/−) than the WT HspB4/αA-crystallin protein. The gene discussed is CRYAA; the disease is diabetes mellitus.